Cereno Scientific AB (publ) (STO:CRNO.B)
8.83
+0.18 (2.08%)
At close: May 8, 2025
Cereno Scientific AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 127.58 | 87.17 | 67.05 | 89.63 | 66 | Upgrade
|
Cash & Short-Term Investments | 127.58 | 87.17 | 67.05 | 89.63 | 66 | Upgrade
|
Cash Growth | 46.36% | 30.01% | -25.20% | 35.80% | 487.38% | Upgrade
|
Other Receivables | 2.88 | 1.12 | 1.25 | 1.36 | 0.84 | Upgrade
|
Receivables | 2.88 | 1.12 | 1.25 | 1.36 | 0.84 | Upgrade
|
Prepaid Expenses | 2.54 | 0.41 | 0.33 | 0.24 | 0.68 | Upgrade
|
Total Current Assets | 133 | 88.7 | 68.63 | 91.24 | 67.52 | Upgrade
|
Property, Plant & Equipment | 1.27 | 0.01 | 0.03 | 0.04 | 0.06 | Upgrade
|
Other Intangible Assets | 13.78 | 13.78 | 11.28 | 9.28 | 7.19 | Upgrade
|
Long-Term Deferred Charges | 265.72 | 182.48 | 135.71 | 80.16 | 37.45 | Upgrade
|
Other Long-Term Assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
Total Assets | 413.77 | 284.99 | 215.65 | 180.74 | 112.23 | Upgrade
|
Accounts Payable | 13.95 | 6.93 | 9.41 | 2.88 | 1.07 | Upgrade
|
Accrued Expenses | 5.5 | 15 | 3.71 | 2.35 | 1.75 | Upgrade
|
Short-Term Debt | - | - | - | 4.8 | 9.12 | Upgrade
|
Current Income Taxes Payable | - | - | 0.21 | 0.03 | 0.03 | Upgrade
|
Other Current Liabilities | 12 | 1.23 | 0.41 | 0.2 | 0.12 | Upgrade
|
Total Current Liabilities | 31.45 | 23.16 | 13.74 | 10.27 | 12.09 | Upgrade
|
Long-Term Debt | 190.4 | 45.4 | 0.4 | 0.4 | 0.4 | Upgrade
|
Total Liabilities | 221.85 | 68.56 | 14.14 | 10.67 | 12.49 | Upgrade
|
Common Stock | 28.17 | 23.38 | 13.75 | 10.53 | 7.18 | Upgrade
|
Additional Paid-In Capital | 271.84 | 299.08 | 245.73 | 189.76 | 106.21 | Upgrade
|
Retained Earnings | -108.09 | -106.04 | -57.97 | -30.22 | -13.65 | Upgrade
|
Comprehensive Income & Other | 0 | - | - | - | - | Upgrade
|
Shareholders' Equity | 191.93 | 216.42 | 201.51 | 170.06 | 99.74 | Upgrade
|
Total Liabilities & Equity | 413.77 | 284.99 | 215.65 | 180.74 | 112.23 | Upgrade
|
Total Debt | 190.4 | 45.4 | 0.4 | 5.2 | 9.52 | Upgrade
|
Net Cash (Debt) | -62.82 | 41.77 | 66.65 | 84.43 | 56.48 | Upgrade
|
Net Cash Growth | - | -37.33% | -21.07% | 49.48% | 4289.74% | Upgrade
|
Net Cash Per Share | -0.22 | 0.18 | 0.48 | 0.80 | 0.78 | Upgrade
|
Filing Date Shares Outstanding | 281.7 | 233.78 | 137.51 | 105.26 | 71.82 | Upgrade
|
Total Common Shares Outstanding | 281.7 | 233.78 | 137.51 | 105.26 | 71.82 | Upgrade
|
Working Capital | 101.55 | 65.54 | 54.89 | 80.96 | 55.43 | Upgrade
|
Book Value Per Share | 0.68 | 0.93 | 1.47 | 1.62 | 1.39 | Upgrade
|
Tangible Book Value | 178.15 | 202.64 | 190.23 | 160.78 | 92.55 | Upgrade
|
Tangible Book Value Per Share | 0.63 | 0.87 | 1.38 | 1.53 | 1.29 | Upgrade
|
Machinery | - | 0.07 | 0.07 | 0.07 | 0.07 | Upgrade
|
Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.